EORTC/MSG definitions

More documents

Recommendations

Info

Definitions - Clinical features Lower respiratory tract infection MAJOR = 1 Chronic disseminated candidiasis Halo sign Air-crescent sign cavity Bull’s eye lesions in liver or spleen Sinonasal infection Radiological evidence Clinical feature CNS infection Radiological evidence Disseminated fungal infection Unexplained papular or nodular skin lesions Chorioretinitis endophthalmitis 2002
Definitions - Clinical features Lower respiratory tract infection Cough, chest pain, haemoptysis, dyspnoea Physical finding of pleural rub Any new infiltrate not fulfilling major criterion Sinonasal infection MINOR = 2 Clinical feature Nasal discharge. stuffiness Nose ulceration. eschar or epistaxis Periorbital swelling Maxillary tenderness Black necrotic lesions or perforation of the hard-palate 2002 CNS infection CSF No pathogens no malignant cells abnormal biochemistry abnormal cell count Focal neurological seizures hemiparesis cranial nerve palsy Mental changes Meningeal irritation
Page 1 and 2:
Update: New EORTC /MSG criteria for
Page 3 and 4:
EORTC-IFICG & NIAID-MSG 2002
Page 5 and 6: Strengths
Page 7 and 8: How valuable do you consider the EO
Page 9 and 10: Strengths EORTC/MSG definitions •
Page 11 and 12: • Why revise? • The process •
Page 13 and 14: Problems INAPPROPRIATE USE • appl
Page 15 and 16: Patient groups at risk of developin
Page 17 and 18: Goal of adapting definitions proven
Page 19 and 20: Answer Host factor neutropenic + Cl
Page 21 and 22: ICAAC 43 Chicago 2003 a) the need f
Page 23 and 24: ICAAC 43 Chicago 2003 - working par
Page 25 and 26: QuickTime and a TIFF (Uncompressed)
Page 27 and 28: Plan B Microbiological Criteria.doc
Page 29 and 30: Round 1 E-mail E-mail E-mail E-mail
Page 31 and 32: Definitions II process Round 1 Roun
Page 33 and 34: QuickTime and a TIFF (Uncompressed)
Page 35 and 36: No change
Page 37 and 38: Defining invasive fungal disease Ho
Page 39 and 40: First change
Page 41 and 42: What’s in a name? Invasive Fungal
Page 43 and 44: Definitions I - Possible invasive f
Page 45 and 46: Invasive fungal disease - Definitio
Page 47 and 48: Definitions II - Possible invasive
Page 49 and 50: Definitions - Host factors neutrope
Page 51 and 52: Definitions - Host factors neutrope
Page 53 and 54: Patients at risk of developing IFD
Page 55: Fourth change
Page 59 and 60: Definitions - Clinical features Low
Page 61 and 62: Specific pulmonary infiltrates on C
Page 63 and 64: Fifth change
Page 65 and 66: Definitions - Mycology Culture of m
Page 67 and 68: Definitions - Mycology Culture of m
Page 69 and 70: Slicing the cake
Page 71 and 72: Separating the chaff from the wheat
Page 73 and 74: Separating the chaff from the wheat
Page 75 and 76: Do you apply EORTC/MSG definitions
Page 77 and 78: Scheme for managing high-risk patie
Page 83 and 84: EORTC/MSG definitions - aspergillos
Page 85 and 86: For example.. CID 2007:44 (15 May)
Page 87 and 88: Table 2. Favorable overall response
Page 89 and 90: At risk population proven probable
Page 91 and 92: Eligible for future studies proven
show all

EORTC/MSG definitions

Create successful ePaper yourself

Delete template?

Save as template?